Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Daily Hand-Held Vibration Therapy for the Reduction of Chemotherapy Induced Peripheral Neuropathy

Trial Status: temporarily closed to accrual

This trial studies the side effects of daily hand-held vibration therapy and to see how well it works in reducing chemotherapy induced peripheral neuropathy (CIPN) in cancer patients who have received neurotoxic chemotherapy. CIPN is a nerve damage (neuropathy) caused by chemotherapy. Vibration therapy uses oscillation (i.e., vibration) to stimulate tissues and surrounding nerves. Typically, vibration is delivered through a device like a small massager that patients hold against their skin for several minutes. Daily hand-held vibration therapy may reduce the severity of patient’s CIPN in their hands and improve CIPN-related quality of life.